SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Synthetic gene design - The rationale for codon optimization and implications for molecular pharming in plants.

Webster, G; Teh, AY-H; Ma, JK-C (2017) Synthetic gene design - The rationale for codon optimization and implications for molecular pharming in plants. Biotechnology and Bioengineering, 114 (3). pp. 492-502. ISSN 0006-3592 https://doi.org/10.1002/bit.26183
SGUL Authors: Teh, Yi Hui

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (674kB) | Preview

Abstract

Degeneracy in the genetic code allows multiple codon sequences to encode the same protein. Codon usage bias in genes is the term given to the preferred use of particular synonymous codons. Synonymous codon substitutions had been regarded as "silent" as the primary structure of the protein was not affected; however, it is now accepted that synonymous substitutions can have a significant effect on heterologous protein expression. Codon optimization, the process of altering codons within the gene sequence to improve recombinant protein expression, has become widely practised. Multiple inter-linked factors affecting protein expression need to be taken into consideration when optimizing a gene sequence. Over the years, various computer programmes have been developed to aid in the gene sequence optimization process. However, as the rulebook for altering codon usage to affect protein expression is still not completely understood, it is difficult to predict which strategy, if any, will design the 'optimal' gene sequence. In this review, codon usage bias and factors affecting codon selection will be discussed and the evidence for codon optimization impact will be reviewed for recombinant protein expression using plants as a case study. These developments will be relevant to all recombinant expression systems, however, molecular pharming in plants is an area which has consistently encountered difficulties with low levels of recombinant protein expression, and should benefit from an evidence based rational approach to synthetic gene design.

Item Type: Article
Additional Information: This is the peer reviewed version of the following article: Webster, G., Teh, A. Y.-H. and Ma, J. K.-C. (2016), Synthetic gene design – The rationale for codon optimization and implications for molecular pharming in plants. Biotechnol. Bioeng., 114: 492–502. Accepted Author Manuscript, which has been published in final form at http://dx.doi.org/10.1002/bit.26183]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Keywords: Synonymous codons, genetic code, heterologous protein expression, Synonymous codons, genetic code, heterologous protein expression, Biotechnology, MD Multidisciplinary
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Biotechnology and Bioengineering
ISSN: 0006-3592
Language: ENG
Dates:
DateEvent
23 January 2017Published
12 September 2016Published Online
5 September 2016Accepted
Publisher License: Publisher's own licence
Projects:
Project IDFunderFunder ID
UNSPECIFIEDEuropean Research Councilhttp://dx.doi.org/10.13039/501100000781
UNSPECIFIEDWellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 27618314
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/108288
Publisher's version: https://doi.org/10.1002/bit.26183

Actions (login required)

Edit Item Edit Item